The Protective Effect of Interleukin-37 on Vascular Calcification and Atherosclerosis in Apolipoprotein E-Deficient Mice with Diabetes

Journal of Interferon and Cytokine Research

Volumn 35, Issue 7, 2015, Pages 530-539

  Chai, Meng ^a,b   Ji, Qingwei ^a,b   Zhang, Haitao ^c   Zhou, Yujie ^a,b   Yang, Qing ^a,b   Zhou, Yangwei ^d   Guo, Guangjin ^c   Liu, Wei ^a,b   Han, Wei ^a,b   Yang, Lixia ^a,b   Zhang, Linlin ^a,b   Liang, Jing ^a,b   Liu, Yuyang ^a,b   Shi, Dongmei ^a,b   Zhao, Yingxin ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c AIR FORCE GENERAL HOSPITAL   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALIZARIN RED S; ALKALINE PHOSPHATASE; ANTIBODY; ANTIINFLAMMATORY AGENT; APOLIPOPROTEIN; BONE MORPHOGENETIC PROTEIN 2; CYTOKINE; EOSIN; HEMATOXYLIN; INTERLEUKIN 18; INTERLEUKIN 37; OSTEOPROTEGERIN; OSTEOPROTEGERIN ANTIBODY; RECOMBINANT HUMAN INTERLEUKIN 37; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; APOLIPOPROTEIN E; AUTACOID; BIOLOGICAL MARKER; CARDIOTONIC AGENT; IL37 PROTEIN, HUMAN; INTERLEUKIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ROOT; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD LEVEL; BLOOD VESSEL CALCIFICATION; CELL DIFFERENTIATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; VON KOSSA STAINING; ANIMAL; BLOOD; BODY WEIGHT; C57BL MOUSE; COMPLICATION; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; VASCULAR CALCIFICATION;

ANIMALIA; MUS;

ALKALINE PHOSPHATASE; ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BIOMARKERS; BODY WEIGHT; BONE MORPHOGENETIC PROTEIN 2; CARDIOTONIC AGENTS; CELL DIFFERENTIATION; DIABETES MELLITUS, EXPERIMENTAL; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; INTERLEUKIN-1; MALE; MICE, INBRED C57BL; OSTEOBLASTS; OSTEOPROTEGERIN; VASCULAR CALCIFICATION;

EID: 84936993007     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2014.0212     Document Type: Article

References (40)

1. Abdelbaky A, Corsini E, Figueroa AL, Fontanez S, Subramanian S, Ferencik M, Brady TJ, Hoffmann U, Tawakol A. 2013. Focal arterial inflammation precedes subsequent calcification in the same location: a longitudinal FDG-PET/CT study. Circ Cardiovasc Imaging 6(5):747-754.
2. Aikawa E, Nahrendorf M, Figueiredo J-L, Swirski FK, Shtatland T, Kohler RH, Jaffer FA, Aikawa M, Weissleder R. 2007. Osteogenesis associates with inflammation in earlystage atherosclerosis evaluated by molecular imaging in vivo. Circulation 116(24):2841-2850.
3. Al-Aly Z, Shao J-S, Lai C-F, Huang E, Cai J, Behrmann A, Cheng S-L, Towler DA. 2007. Aortic Msx2-Wnt calcification cascade is regulated by TNF-a-dependent signals in diabetic Ldlr - / - mice. Arterioscler Thromb Vasc Biol 27(12):2589-2596.
4. Bennett BJ, Scatena M, Kirk EA, Rattazzi M, Varon RM, Averill M, Schwartz SM, Giachelli CM, Rosenfeld ME. 2006. Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE- / - mice. Arterioscler Thromb Vasc Biol 26(9):2117-2124.
5. Boraschi D, Lucchesi D, Hainzl S, Leitner M, Maier E, Mangelberger D, Oostingh GJ, Pfaller T, Pixner C, Posselt G, Italiani P, Nold MF, Nold-Petry CA, Bufler P, Dinarello CA. 2011. IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw 22(3):127-147.
6. Boyle JJ. 2005. Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture. Curr Vasc Pharmacol 3(1):63-68.
7. Budoff MJ, Hokanson JE, Nasir K, Shaw LJ, Kinney GL, Chow D, Demoss D, Nuguri V, Nabavi V, Ratakonda R, Berman DS, Raggi P. 2010. Progression of coronary artery calcium predicts all-cause mortality. JACC Cardiovasc Imaging 3(12):1229-1236.
8. Chen N, Duan D, Oneill K, Wolisi G, Koczman J, Laclair R, Moe S. 2006. The mechanisms of uremic serum-induced expression of bone matrix proteins in bovine vascular smooth muscle cells. Kidney Int 70(6):1046-1053.
9. Csiszar A, Smith KE, Koller A, Kaley G, Edwards JG, Ungvari Z. 2005. Regulation of bone morphogenetic protein-2 expression in endothelial cells role of nuclear factor-kB activation by tumor necrosis factor-a, H2O2, and high intravascular pressure. Circulation 111(18):2364-2372.
10. Elhage R, Jawien J, Rudling M, Ljunggren HG, Takeda K, Akira S, Bayard F, Hansson GK. 2003. Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc Res 59(1):234-240.
11. Ji Q, Zeng Q, Huang Y, Shi Y, Lin Y, Lu Z, Meng K, Wu B, Yu K, Chai M, Liu Y, Zhou Y. 2014. Elevated plasma IL-37, IL- 18, and IL-18BP concentrations in patients with acute coronary syndrome. Mediators Inflamm 2014:165742.
12. Johnson RC, Leopold JA, Loscalzo J. 2006. Vascular calcification pathobiological mechanisms and clinical implications. Circ Res 99(10):1044-1059.
13. Jono S, Ikari Y, Shioi A, Mori K, Miki T, Hara K, Nishizawa Y. 2002. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation 106(10):1192-1194.
14. Kober F, Canault M, Peiretti F, Mueller C, Kopp F, Alessi MC, Cozzone PJ, Nalbone G, Bernard M. 2007. MRI follow-up of TNF-dependent differential progression of atherosclerotic wall-thickening in mouse aortic arch from early to advanced stages. Atherosclerosis 195(2):e93-e99.
15. Li H, Hong S, Qian J, Zheng Y, Yang J, Yi Q. 2010. Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4 + and CD8 + T cells. Blood 116(2):210-217.
16. Li X, Yang H-Y, Giachelli CM. 2008. BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis 199(2): 271-277.
17. Liu Y, Li D, Chen J, Xie J, Bandyopadhyay S, Zhang D, Nemarkommula AR, Liu H, Mehta JL, Hermonat PL. 2006. Inhibition of atherogenesis in LDLR knockout mice by systemic delivery of adeno-associated virus type 2-hIL-10. Atherosclerosis 188(1):19-27.
18. Luo XH, Zhao LL, Yuan LQ, Wang M, Xie H, Liao EY. 2009. Development of arterial calcification in adiponectin-deficient mice: adiponectin regulates arterial calcification. J Bone Miner Res 24(8):1461-1468.
19. McNamee EN, Masterson JC, Jedlicka P, McManus M, Grenz A, Collins CB, Nold MF, Nold-Petry C, Bufler P, Dinarello CA, Rivera-Nieves J. 2011. Interleukin 37 expression protects mice from colitis. Proc Natl Acad Sci U S A 108(40): 16711-16716.
20. Menini S, Iacobini C, Ricci C, Oddi G, Pesce C, Pugliese F, Block K, Abboud HE, Giorgio M, Migliaccio E, Pelicci PG, Pugliese G. 2007. Ablation of the gene encoding p66Shc protects mice against AGE-induced glomerulopathy by preventing oxidant-dependent tissue injury and further AGE accumulation. Diabetologia 50(9):1997-2007.
21. Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA. 2010. IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 11(11):1014-1022.
22. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F. 2002. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106(1):100-105.
23. Phan O, Ivanovski O, Nguyen-Khoa T, Mothu N, Angulo J, Westenfeld R, Ketteler M, Meert N, Maizel J, Nikolov IG, Vanholder R, Lacour B, Drueke TB, Massy ZA. 2005. Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice. Circulation 112(18): 2875-2882.
24. Price PA, June HH, Buckley JR, Williamson MK. 2001. Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol 21(10): 1610-1616.
25. Sage AP, Tintut Y, Demer LL. 2010. Regulatory mechanisms in vascular calcification. Nat Rev Cardiol 7(9):528-536.
26. Sakai N, Van Sweringen HL, Belizaire RM, Quillin RC, Schuster R, Blanchard J, Burns JM, Tevar AD, Edwards MJ, Lentsch AB. 2012. Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells. J Gastroenterol Hepatol 27(10):1609-1616.
27. Samelson EJ, Miller PD, Christiansen C, Daizadeh NS, Grazette L, Anthony MS, Egbuna O, Wang A, Siddhanti SR, Cheung AM, Franchimont N, Kiel DP.2014. RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification or incidence of adverse cardiovascular events in postmenopausal women with osteoporosis and high cardiovascular risk RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification. J Bone Miner Res 29(2):450-457.
28. Shanahan CM, Cary NR, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME. 1999. Medial localization of mineralization- regulating proteins in association with Mönckebergs sclerosis evidence for smooth muscle cell-mediated vascular calcification. Circulation 100(21):2168-2176.
29. Shiomi M, Ito T, Hirouchi Y, Enomoto M. 2001. Stability of atheromatous plaque affected by lesional composition: study of WHHL rabbits treated with statins. Ann N Y Acad Sci 947:419-423.
30. Shroff RC, McNair R, Figg N, Skepper JN, Schurgers L, Gupta A, Hiorns M, Donald AE, Deanfield J, Rees L. 2008. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 118(17):1748-1757.
31. Speer MY, Giachelli CM. 2004. Regulation of cardiovascular calcification. Cardiovasc Pathol 13(2):63-70.
32. Stompor T, Krasniak A, Su1owicz W, Dembinska-Kiec A, Janda K, Wojcik K, Tabor B, Kowalczyk-Micha1ek ME, Zdzienicka A, Janusz-Grzybowska E. 2005. Changes in common carotid artery intima-media thickness over 1 year in patients on peritoneal dialysis. Nephrol Dial Transplant 20(2):404-412.
33. Takaoka M, Nagata D, Kihara S, Shimomura I, Kimura Y, Tabata Y, Saito Y, Nagai R, Sata M. 2009. Periadventitial adipose tissue plays a critical role in vascular remodeling. Circ Res 105(9):906-911.
34. Tete S, Tripodi D, Rosati M, Conti F, Maccauro G, Saggini A, Cianchetti E, Caraffa A, Antinolfi P, Toniato E, Castellani ML, Conti P, Theoharides TC. 2012. IL-37 (IL-1F7) the newest anti-inflammatory cytokine which suppresses immune responses and inflammation. Int J Immunopathol Pharmacol 25(1):31-38.
35. Tintut Y, Patel J, Territo M, Saini T, Parhami F, Demer LL. 2002. Monocyte/macrophage regulation of vascular calcification in vitro. Circulation 105(5): 650-655.
36. Wang Z, Jiang Y, Liu N, Ren L, Zhu Y, An Y, Chen D. 2012. Advanced glycation end-product Nepsilon-carboxymethyl- Lysine accelerates progression of atherosclerotic calcification in diabetes. Atherosclerosis 221(2):387-396.
37. Whyte MP. 1994. Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev 15(4):439-461.
38. Wu B, Meng K, Ji Q, Cheng M, Yu K, Zhao X, Tony H, Liu Y, Zhou Y, Chang C, Zhong Y, Zhu Z, Zhang W, Mao X, Zeng Q. 2014. Interleukin-37 ameliorates myocardial ischaemia/ reperfusion injury in mice. Clin Exp Immunol 176(3):438-451.
39. Xie H, Xie P-L, Wu X-P, Chen S-M, Zhou H-D, Yuan L-Q, Sheng Z-F, Tang S-Y, Luo X-H, Liao E-Y. 2011. Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin- deficient mice by inhibition of RANKL expression. Cardiovasc Res 92(2):296-306.
40. Zeadin M, Butcher M, Werstuck G, Khan M, Yee CK, Shaughnessy SG. 2009. Effect of leptin on vascular calcification in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 29(12):2069-2075.